Contents:

GENERAL INFORMATION

 About Radiosurgery

 About Brain Tumors

 What to Expect

WHO WE ARE

 Our Experts

 Our Services

 Request Consultation

DISORDERS WE TREAT

 Acoustic Neuroma

 Brain AVM

 Chordoma

 Craniopharyngioma

 Glioma

 Hemangioblastoma

 Meningioma

 Metastases

 Pineal Tumors

 Pituitary Adenoma

 Trigeminal Neuralgia

 Vestibular Schwannoma

TREATMENT OPTIONS

 Fractionated Stereotactic  Radiosurgery

 Gamma Knife

 Linear Accelerator

RESOURCES

 Glossary

 Useful Links

 Image Recovery Center

 Hopkins USA

 Hopkins Access Line

 Travel and Accommodation

CONTACT US

Home | Neurology/Neurosurgery

 

Hopkins Medicine | Directions | Appointments

Johns Hopkins Medicine
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Stereotactic Radiosurgery
 

Disorders We Treat

> acoustic neuroma 

> meningioma

> brain AVM

> metastases

> chordoma

> pineal tumors

> craniopharyngioma

> pituitary adenomas

> glioma

> trigeminal neuralgia

> hemangioblastoma

> vestibular schwannoma

Hemangioblastoma

Hemangioblastomas are a diverse group of brain tumors which arise from the normal "glial" cells of the brain. These cells outnumber the "neurons" that conduct impulses and serve to provide metabolic support to the neurons. The hemangioblastomas have specific signs and symptoms that are primarily related to their location.

Cerebellar hemangioblastomas may cause difficulty with gait (ataxia), co-ordination or nystagmus (oscillation of the eyes on lateral gaze toward the side of the tumor). Larger tumors may cause hydrocephalus. On occasion the polycythemia caused by the hemangioblastoma may result in deep venous thrombosis or other vascular abnormality.
Temporal lobe hemangioblastomas may cause epilepsy, difficulty with speech, or loss of memory.
Frontal lobe hemangioblastomas may cause behavioral changes, weakness of the arms or legs, or difficulty with speech.
Occipital hemangioblastomas may cause loss of vision.
Parietal hemangioblastomas may cause loss of spatial orientation, diminished sensation on the opposite side of the body, or inability to recognize once familiar objects or persons.

The most important aspect of the hemangioblastoma in determining treatment is size:
Small in size (usually less than 3 centimeters in diameter).
Deep location rendering resection difficult or hazardous.
Well demarcated on MRI.

Many patients undergo a series of treatments for hemangioblastomas including multiple surgical resections, conventional external beam radiotherapy and possibly systemic chemotherapy. Radiosurgery, or the gamma knife, is a consideration even in the context of intense prior treatments. This is because radiotherapy limits dose to the tumor, sparing normal brain.

Hemangioblastoma is most frequent in the 35-to-45 age group. The most common site is the cerebellum. It is slow growing and does not metastasize. This tumor causes increased intracranial pressure and cerebellar dysfunction. Symptoms are headache, vomiting and nausea, gait disturbance, and balance problems.

Both CT and MRI scans are capable of detecting the hemangioblastoma. Angiography is rarely done before surgery to confirm the diagnosis. Surgery is the treatment of choice. Incompletely removed tumors or tumors attached to the brain stem may be treated with radiosurgery.

The decisions related to treatment for hemangioblastomas including cerebellar hemangioblastomas and cystic hemangioblastomas, depend upon the complete understanding of the competing risks vs. benefits for the different treatments. Options for hemangioblastoma treatment may include surgery, radiosurgery and gamma knife. The important considerations include the size and rate of growth of the hemangioblastoma as well as the progression of any symptoms.

 

Johns Hopkins Radiosurgery
401 N. Broadway, Weinberg 1469,
Baltimore, MD 21231-2410
phone: 410-955-6980

Disclaimer